Skip to main content
. Author manuscript; available in PMC: 2020 May 9.
Published in final edited form as: J Med Chem. 2019 Apr 30;62(9):4669–4682. doi: 10.1021/acs.jmedchem.9b00274

Table 6.

TDP2 inhibitory activity, permeability and cytotoxicity profiles of selected analogues.

Compd TDP2 IC50 (μM)a PAMPA Pe (10−6 cm/s)b CC50 (μM)c
HepG2 HeLa
11a 0.20 ± 0.02 1.2 14 12
11e 0.15 ± 0.01 0.6 29 29
12a 0.033 ± 0.001 0.1 50 >100
12b 0.033 ± 0.002 0.08 41 45
12g 0.0073 ± 0.0003 0.04 85 65
12h 0.020 ± 0.002 0.07 82 90
12j 0.0065 ± 0.0004 0.02 >100 >100
12k 0.0061 ± 0.0006 0.06 >100 >100
4ad 0.041 ± 0.003 0.003 >100 >100
4bd 0.042 ± 0.004 0.01 >100 --
4cd 0.14 ± 0.01 0.008 >100 --
a

IC50: concentration of a compound producing 50% inhibition, expressed as mean ± standard deviation from three independent experiments.

b

Pe: effective permeability coefficients determined using the PAMPA, measured in five replicates.

c

CC50: concentration of a compound causing 50% cell death.

d

Previously reported15 analogues.